adalimumab
PulseAugur coverage of adalimumab — every cluster mentioning adalimumab across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Mura Bio targets immune cell metabolism for autoimmune disease treatments
Mura Bio, a startup co-founded by Dr. Xu Ke, is developing novel treatments for autoimmune diseases by targeting the metabolic pathways of immune cells. Their lead candidate, MP-5342, is an oral LDHA inhibitor designed …
-
Cigna Group leverages AI for $200M cost savings and improved patient care
Cigna Group is leveraging AI and predictive analytics to achieve significant cost savings and improve patient outcomes. The company projects that its AI tools for identifying chronic conditions will save $200 million ov…
-
Drug prices fall as Biden's Medicare negotiation and competition outweigh Trump's deals
Recent data indicates a decrease in U.S. prescription drug prices, with a 0.8% drop in July and a 3.1% decrease year-over-year. While former President Donald Trump has claimed credit for this trend, attributing it to hi…
-
Congress targets insulin costs and drug patent abuses
Congress is advancing legislation aimed at reducing prescription drug costs and reforming patent practices. The INSULIN Act, which has passed a key Senate committee, proposes capping out-of-pocket insulin costs at $35 p…
-
AssemblyAI ranks top medical speech recognition tools for 2026
AssemblyAI has released a guide detailing the top 8 medical speech recognition software and APIs for 2026. The guide emphasizes the importance of accuracy in transcribing medical terms, drug names, and dosages, highligh…
-
AbbVie buys Apogee for $10.9B; AI startup Cadence raises $100M
AbbVie has acquired Apogee Therapeutics for $10.9 billion to bolster its immunology franchise with Apogee's lead drug, zumilokibart, which shows promise in treating autoimmune conditions. Separately, the AI startup Cade…